BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sepah YJ, Velez G, Tang PH, Yang J, Chemudupati T, Li AS, Nguyen QD, Bassuk AG, Mahajan VB. Proteomic analysis of intermediate uveitis suggests myeloid cell recruitment and implicates IL-23 as a therapeutic target. Am J Ophthalmol Case Rep 2020;18:100646. [PMID: 32274442 DOI: 10.1016/j.ajoc.2020.100646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Eskandarpour M, Nunn MA, Weston-Davies W, Calder VL. Immune-Mediated Retinal Vasculitis in Posterior Uveitis and Experimental Models: The Leukotriene (LT)B4-VEGF Axis. Cells 2021;10:396. [PMID: 33671954 DOI: 10.3390/cells10020396] [Reference Citation Analysis]
2 Li S, Liu F, Zhang K, Tong Y, Liu X. Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis. J Immunol Res 2021;2021:6683411. [PMID: 34778467 DOI: 10.1155/2021/6683411] [Reference Citation Analysis]
3 Coronado BNL, da Cunha FBS, de Toledo Nobrega O, Martins AMA. The impact of mass spectrometry application to screen new proteomics biomarkers in Ophthalmology. Int Ophthalmol 2021;41:2619-33. [PMID: 33811281 DOI: 10.1007/s10792-021-01807-z] [Reference Citation Analysis]
4 Bansal R, Gupta A. Protein Biomarkers in Uveitis. Front Immunol 2020;11:610428. [PMID: 33343583 DOI: 10.3389/fimmu.2020.610428] [Cited by in F6Publishing: 1] [Reference Citation Analysis]